Saturday 12 July 2014

Firm to market breast cancer drug in ME

Japan-based Eisai will market its breast cancer treatment Halaven (eribulin) in selected countries within the Middle East region through a new partnership between Eisai EMEA and NewBridge Pharmaceuticals. Eribulin is indicated for


Eisai's breast cancer drug ‘extends lives’

Eisai's experimental breast cancer drug eribulin added an average of two and a half months to the lives of patients dying of breast cancer, which is a big improvement in such seriously ill cancer patients, researchers said. The results of

 1 2 3 4 5 >  Last ›

calendarCalendar of Events


Buy high quality China wholesale Health & Beauty , Electronics, Sports & Outdoors , Computers, Video Games, Toys & Hobbies Cell Phones, Automobiles and other wholesale products directly from reliable Chinese wholesalers or Factories on